Photocure

50,5NOK -3,44 %
Vær den første som følger denne virksomhed

Photocure is a medical technology company. The company specializes in solutions for photodynamic technology. The solutions are used to treat diseases that have caused bladder cancer and HPV. The main markets are in dermatology and oncology, where the products are used by hospitals and research institutes on a global level. The company was founded in 1993 and is headquartered in Oslo, Norway.

Omsætning
393,13 mio.
EBIT %
-12,46 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
PHO
Daglig lav / høj pris
50,5 / 52,1 NOK
Markedsværdi
1,37 mia. NOK
Aktieomsætning
595 t NOK
Volumen
12 t

Finanskalender

PHO: Major shareholder disclosure

Selskabsmeddelelse01.06.2023
Photocure ASA: Annual Report 2022

Selskabsmeddelelse12.04.2023
Photocure ASA: Annual Report 2022

Selskabsmeddelelse12.04.2023